Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

Completed · Phase 1

Conditions studied: Chronic Hepatitis C, Organ Transplantation, Immunosuppression

In brief

Liver transplant subjects will be given Mycophenolate (MMF) and Tacrolimus in order to help prevent post-transplant rejection.

Key facts

Study ID

NCT00286871

Run by

Duke University

People needed

40

Starts

2006-02-01

Expected to finish

2009-02-01

Last updated by the study team

2014-09-22

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients who have received liver transplant

You may not qualify if…

• pregnant women
• nursing women

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.